Gary Jackson

Array ( [id] => 4853108 [patent_doc_number] => 20080318851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex' [patent_app_type] => utility [patent_app_number] => 11/485169 [patent_app_country] => US [patent_app_date] => 2006-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9139 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318851.pdf [firstpage_image] =>[orig_patent_app_number] => 11485169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 556582 [patent_doc_number] => 07470522 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-12-30 [patent_title] => 'Isolated genomic polynucleotide fragments encoding human resistin and the human syntaxin binding protein 2' [patent_app_type] => utility [patent_app_number] => 11/483373 [patent_app_country] => US [patent_app_date] => 2006-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11251 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/470/07470522.pdf [firstpage_image] =>[orig_patent_app_number] => 11483373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391690 [patent_doc_number] => 20090209003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'MUTANT PCNA' [patent_app_type] => utility [patent_app_number] => 11/994437 [patent_app_country] => US [patent_app_date] => 2006-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 33361 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11994437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485716 [patent_doc_number] => 20090275481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Anchored Transferrin Fusion Protein Libraries' [patent_app_type] => utility [patent_app_number] => 12/067436 [patent_app_country] => US [patent_app_date] => 2006-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 29610 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275481.pdf [firstpage_image] =>[orig_patent_app_number] => 12067436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141793 [patent_doc_number] => 20070004009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Methods for making recombinant proteins using apoptosis inhibitors' [patent_app_type] => utility [patent_app_number] => 11/454670 [patent_app_country] => US [patent_app_date] => 2006-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13703 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004009.pdf [firstpage_image] =>[orig_patent_app_number] => 11454670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32664 [patent_doc_number] => 07790673 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Methods and compositions relating to cystatin C' [patent_app_type] => utility [patent_app_number] => 11/451516 [patent_app_country] => US [patent_app_date] => 2006-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 52 [patent_no_of_words] => 22072 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790673.pdf [firstpage_image] =>[orig_patent_app_number] => 11451516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602892 [patent_doc_number] => 20060293237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'PsiepsilonRACK peptide composition and method for protection against tissue damage due to ischemia' [patent_app_type] => utility [patent_app_number] => 11/449966 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7768 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293237.pdf [firstpage_image] =>[orig_patent_app_number] => 11449966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183498 [patent_doc_number] => 20070054852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Compositions and methods of use of Semaphorin 3F and antagonists thereof in the stimulation of neuromuscular regeneration and treatment of muscular diseases' [patent_app_type] => utility [patent_app_number] => 11/442294 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25525 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054852.pdf [firstpage_image] =>[orig_patent_app_number] => 11442294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183497 [patent_doc_number] => 20070054851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases' [patent_app_type] => utility [patent_app_number] => 11/442244 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 59690 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054851.pdf [firstpage_image] =>[orig_patent_app_number] => 11442244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851097 [patent_doc_number] => 20060234288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto' [patent_app_type] => utility [patent_app_number] => 11/441861 [patent_app_country] => US [patent_app_date] => 2006-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 22111 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234288.pdf [firstpage_image] =>[orig_patent_app_number] => 11441861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 817136 [patent_doc_number] => 07410944 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-08-12 [patent_title] => 'Depression gene' [patent_app_type] => utility [patent_app_number] => 11/441887 [patent_app_country] => US [patent_app_date] => 2006-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26750 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/410/07410944.pdf [firstpage_image] =>[orig_patent_app_number] => 11441887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999829 [patent_doc_number] => 20070042463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof' [patent_app_type] => utility [patent_app_number] => 11/441688 [patent_app_country] => US [patent_app_date] => 2006-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 30824 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042463.pdf [firstpage_image] =>[orig_patent_app_number] => 11441688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6254721 [patent_doc_number] => 20100028940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Compositions and Methods for Metabolic Selection of Transfected Cells' [patent_app_type] => utility [patent_app_number] => 11/914725 [patent_app_country] => US [patent_app_date] => 2006-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10349 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028940.pdf [firstpage_image] =>[orig_patent_app_number] => 11914725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 860440 [patent_doc_number] => 07371723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Therapeutic agents comprising pro-apoptotic proteins' [patent_app_type] => utility [patent_app_number] => 11/415342 [patent_app_country] => US [patent_app_date] => 2006-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 49211 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371723.pdf [firstpage_image] =>[orig_patent_app_number] => 11415342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 585925 [patent_doc_number] => 07439027 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Method for modulating process mediated by farnesoid activated receptors' [patent_app_type] => utility [patent_app_number] => 11/413604 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 6890 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439027.pdf [firstpage_image] =>[orig_patent_app_number] => 11413604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705684 [patent_doc_number] => 20060194732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation' [patent_app_type] => utility [patent_app_number] => 11/413197 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4612 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194732.pdf [firstpage_image] =>[orig_patent_app_number] => 11413197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5759628 [patent_doc_number] => 20060210573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Peptide useful in immunomodulation' [patent_app_type] => utility [patent_app_number] => 11/411832 [patent_app_country] => US [patent_app_date] => 2006-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11716 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210573.pdf [firstpage_image] =>[orig_patent_app_number] => 11411832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 408317 [patent_doc_number] => 07285635 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-23 [patent_title] => 'Modified proteins, designer toxins, and methods of making thereof' [patent_app_type] => utility [patent_app_number] => 11/410514 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 51394 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285635.pdf [firstpage_image] =>[orig_patent_app_number] => 11410514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627646 [patent_doc_number] => 20100004163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Composition and Uses of a Galectin for Treatment of Dry Eye Syndrome' [patent_app_type] => utility [patent_app_number] => 11/918393 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 21445 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004163.pdf [firstpage_image] =>[orig_patent_app_number] => 11918393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 466774 [patent_doc_number] => 07235364 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'CICKb mutation as a diagnostic and therapeutical target' [patent_app_type] => utility [patent_app_number] => 11/398208 [patent_app_country] => US [patent_app_date] => 2006-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5279 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235364.pdf [firstpage_image] =>[orig_patent_app_number] => 11398208 [rel_patent_id] =>[rel_patent_doc_number] =>)